Annual ROA
-15.91%
+38.05%+70.52%
31 December 2023
Summary:
Y-mAbs Therapeutics annual return on assets is currently -15.91%, with the most recent change of +38.05% (+70.52%) on 31 December 2023. During the last 3 years, it has risen by +74.46% (+82.39%). YMAB annual ROA is now at all-time high.YMAB ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-18.50%
+0.25%+1.33%
30 September 2024
Summary:
Y-mAbs Therapeutics quarterly return on assets is currently -18.50%, with the most recent change of +0.25% (+1.33%) on 30 September 2024. Over the past year, it has dropped by -4.41% (-31.30%). YMAB quarterly ROA is now -31.30% below its all-time high of -14.09%, reached on 30 September 2023.YMAB Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YMAB ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +70.5% | -31.3% |
| 3 y3 years | +82.4% | -9.4% |
| 5 y5 years | +44.1% | +66.5% |
YMAB ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +82.4% | -31.3% | +73.6% |
| 5 y | 5 years | at high | +82.4% | -31.3% | +75.3% |
| alltime | all time | at high | +83.9% | -31.3% | +75.3% |
Y-mAbs Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -18.50%(-1.3%) |
| June 2024 | - | -18.75%(+12.5%) |
| Mar 2024 | - | -16.67%(+3.9%) |
| Dec 2023 | -15.91%(-70.5%) | -16.04%(+13.8%) |
| Sept 2023 | - | -14.09%(-48.0%) |
| June 2023 | - | -27.11%(-42.8%) |
| Mar 2023 | - | -47.42%(-15.2%) |
| Dec 2022 | -53.96%(+68.3%) | -55.93%(-20.2%) |
| Sept 2022 | - | -70.11%(+11.0%) |
| June 2022 | - | -63.15%(+27.4%) |
| Mar 2022 | - | -49.55%(+100.7%) |
| Dec 2021 | -32.06% | -24.69%(+46.0%) |
| Sept 2021 | - | -16.91%(-19.1%) |
| June 2021 | - | -20.89%(-37.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | -33.31%(-55.6%) |
| Dec 2020 | -90.37%(+141.3%) | -74.98%(+10.3%) |
| Sept 2020 | - | -67.99%(+1.9%) |
| June 2020 | - | -66.70%(+17.0%) |
| Mar 2020 | - | -57.03%(+3.1%) |
| Dec 2019 | -37.45%(+31.5%) | -55.30%(+0.2%) |
| Sept 2019 | - | -55.17%(+35.6%) |
| June 2019 | - | -40.70%(+4.6%) |
| Mar 2019 | - | -38.92%(+17.4%) |
| Dec 2018 | -28.48%(+36.9%) | -33.15%(-4.7%) |
| Sept 2018 | - | -34.78%(-6.8%) |
| June 2018 | - | -37.32%(+67.2%) |
| Mar 2018 | - | -22.32%(+57.2%) |
| Dec 2017 | -20.80%(-79.0%) | -14.20% |
| Dec 2016 | -98.82% | - |
FAQ
- What is Y-mAbs Therapeutics annual return on assets?
- What is the all time high annual ROA for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics annual ROA year-on-year change?
- What is Y-mAbs Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics quarterly ROA year-on-year change?
What is Y-mAbs Therapeutics annual return on assets?
The current annual ROA of YMAB is -15.91%
What is the all time high annual ROA for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual return on assets is -15.91%
What is Y-mAbs Therapeutics annual ROA year-on-year change?
Over the past year, YMAB annual return on assets has changed by +38.05% (+70.52%)
What is Y-mAbs Therapeutics quarterly return on assets?
The current quarterly ROA of YMAB is -18.50%
What is the all time high quarterly ROA for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly return on assets is -14.09%
What is Y-mAbs Therapeutics quarterly ROA year-on-year change?
Over the past year, YMAB quarterly return on assets has changed by -4.41% (-31.30%)